跳至主要内容
临床试验/NL-OMON30544
NL-OMON30544尚未招募不适用

Acetylcysteine for Treatment of Sickle Cell Disease - N-acetylcystein for Sickle Cell Disease

Academisch Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. High performance liquid chromatography confirmed diagnosis of HbSS, HbSC or HbSb genotype
  • 2. Aged 18-65 years
  • 3. Written informed consent

排除标准

  • 1. Bloodtransfusion in the preceding four months
  • 2. Pregnancy or the desire to get pregnant in the following 7 months
  • 3. Concommitant use of hydroxyurea, oral anticontraceptives or other estrogen containing preparations, vitamin K antagonists or other oral anticoagulants, or contraindications for NAC.
  • 4. Impaired renal function of more than 60% (as assessed by the Kockroft-Gauld equation)
  • 5. Known gatsric or duodenal ulcer
  • 6. Concomittant use of anti-hypertensives, sildefanil or nitrates.

研究者

相似试验